IL192148A0 - A complex formulation for oral administration containing amlodipine camsylate and simvastatin - Google Patents
A complex formulation for oral administration containing amlodipine camsylate and simvastatinInfo
- Publication number
- IL192148A0 IL192148A0 IL192148A IL19214808A IL192148A0 IL 192148 A0 IL192148 A0 IL 192148A0 IL 192148 A IL192148 A IL 192148A IL 19214808 A IL19214808 A IL 19214808A IL 192148 A0 IL192148 A0 IL 192148A0
- Authority
- IL
- Israel
- Prior art keywords
- simvastatin
- oral administration
- administration containing
- complex formulation
- containing amlodipine
- Prior art date
Links
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 title 1
- UXKMFEPPKJZDAR-STOWLHSFSA-N [(1r,4s)-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid;3-o-ethyl 5-o-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl UXKMFEPPKJZDAR-STOWLHSFSA-N 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 title 1
- 229960002855 simvastatin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020050130531A KR100742432B1 (ko) | 2005-12-27 | 2005-12-27 | 암로디핀 캠실레이트 및 심바스타틴을 포함하는 복합제제,및 이의 제조방법 |
| PCT/KR2006/005658 WO2007075009A1 (en) | 2005-12-27 | 2006-12-22 | Complex formulation comprising amlodipine camsylate and simvastatin and method for preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL192148A0 true IL192148A0 (en) | 2009-08-03 |
Family
ID=38218207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL192148A IL192148A0 (en) | 2005-12-27 | 2008-06-12 | A complex formulation for oral administration containing amlodipine camsylate and simvastatin |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090005425A1 (enExample) |
| EP (1) | EP1978956A4 (enExample) |
| JP (1) | JP2009521526A (enExample) |
| KR (1) | KR100742432B1 (enExample) |
| CN (1) | CN101346140A (enExample) |
| AU (1) | AU2006330199A1 (enExample) |
| BR (1) | BRPI0620790A2 (enExample) |
| CA (1) | CA2634639A1 (enExample) |
| IL (1) | IL192148A0 (enExample) |
| RU (1) | RU2008130873A (enExample) |
| WO (1) | WO2007075009A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY173823A (en) * | 2009-01-23 | 2020-02-24 | Hanmi Science Co Ltd | Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same |
| WO2010107081A1 (ja) * | 2009-03-19 | 2010-09-23 | 第一三共株式会社 | 包装により安定保存された固形製剤 |
| CN101836981B (zh) * | 2009-12-01 | 2011-12-14 | 严洁 | 复方缬沙坦苯磺酸氨氯地平药物组合物及其制备方法 |
| WO2011112993A2 (en) | 2010-03-11 | 2011-09-15 | University Of Louisville Research Foundation, Inc. | Methods of predicting and decreasing the risk of pregnancy loss |
| KR20120068277A (ko) * | 2010-12-17 | 2012-06-27 | 한미사이언스 주식회사 | ＨＭＧ－ＣｏＡ 환원효소 억제제 및 아스피린을 포함하는 약제학적 복합제제 |
| BR112014003529A2 (pt) * | 2011-08-15 | 2017-03-14 | Technion Res & Dev Foundation | combinações de corroles e estatinas |
| WO2014058046A1 (ja) * | 2012-10-12 | 2014-04-17 | 味の素株式会社 | カルシウム拮抗薬／アンジオテンシンｉｉ受容体拮抗薬含有医薬製剤 |
| KR20200009101A (ko) | 2017-10-17 | 2020-01-29 | 한미약품 주식회사 | 암로디핀, 로자탄 및 로수바스타틴을 포함하는 당뇨병을 동반한 심혈관계 질환의 예방 또는 치료용 약학 조성물 및 이를 포함하는 복합제제 |
| KR20190043076A (ko) | 2017-10-17 | 2019-04-25 | 한미약품 주식회사 | 암로디핀, 로자탄 및 로수바스타틴을 포함하는 당뇨병을 동반한 심혈관계 질환의 예방 또는 치료용 약학 조성물 및 이를 포함하는 복합제제 |
| KR102306888B1 (ko) | 2019-11-25 | 2021-09-29 | 성균관대학교산학협력단 | 구멍쇠미역으로부터 분리된 신규 화합물을 유효성분으로 포함하는 동맥경화 예방 및 치료용 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ502283A (en) | 1997-08-29 | 2002-05-31 | Pfizer Prod Inc | Cardiovascular therapy comprising amlodipine and a statin compound in amounts that are synergistically effective |
| US20030092745A1 (en) | 2000-02-25 | 2003-05-15 | Pfizer Inc. | Combination therapy |
| EP1314425A4 (en) | 2000-08-30 | 2004-06-02 | Sankyo Co | MEDICINAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE |
| DE10224612A1 (de) * | 2002-06-04 | 2003-12-24 | Lohmann Therapie Syst Lts | Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung |
| BRPI0407038A (pt) | 2003-01-27 | 2006-01-17 | Hanmi Pharm Ind Co Ltd | Camsilato de amlodipina amorfo estável, processo para a preparação do mesmo e composição para administração oral deste |
| US7611728B2 (en) | 2003-09-05 | 2009-11-03 | Supernus Pharmaceuticals, Inc. | Osmotic delivery of therapeutic compounds by solubility enhancement |
| WO2006059217A1 (en) * | 2004-12-01 | 2006-06-08 | Ranbaxy Laboratories Limited | Stable solid dosage forms of amlodipine besylate and processes for their preparation |
| KR100582347B1 (ko) * | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법 |
-
2005
- 2005-12-27 KR KR1020050130531A patent/KR100742432B1/ko not_active Expired - Fee Related
-
2006
- 2006-12-22 EP EP06835362A patent/EP1978956A4/en not_active Withdrawn
- 2006-12-22 BR BRPI0620790-1A patent/BRPI0620790A2/pt not_active IP Right Cessation
- 2006-12-22 WO PCT/KR2006/005658 patent/WO2007075009A1/en not_active Ceased
- 2006-12-22 CA CA002634639A patent/CA2634639A1/en not_active Abandoned
- 2006-12-22 US US12/159,418 patent/US20090005425A1/en not_active Abandoned
- 2006-12-22 CN CNA2006800492048A patent/CN101346140A/zh active Pending
- 2006-12-22 RU RU2008130873/15A patent/RU2008130873A/ru not_active Application Discontinuation
- 2006-12-22 JP JP2008548399A patent/JP2009521526A/ja not_active Withdrawn
- 2006-12-22 AU AU2006330199A patent/AU2006330199A1/en not_active Abandoned
-
2008
- 2008-06-12 IL IL192148A patent/IL192148A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006330199A1 (en) | 2007-07-05 |
| CN101346140A (zh) | 2009-01-14 |
| US20090005425A1 (en) | 2009-01-01 |
| BRPI0620790A2 (pt) | 2011-11-22 |
| CA2634639A1 (en) | 2007-07-05 |
| RU2008130873A (ru) | 2010-02-10 |
| EP1978956A1 (en) | 2008-10-15 |
| KR100742432B1 (ko) | 2007-07-24 |
| WO2007075009A1 (en) | 2007-07-05 |
| KR20070068658A (ko) | 2007-07-02 |
| EP1978956A4 (en) | 2009-08-19 |
| JP2009521526A (ja) | 2009-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL192148A0 (en) | A complex formulation for oral administration containing amlodipine camsylate and simvastatin | |
| IL198869A0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING A PDGFRa ANTAGONIST | |
| ZA200606229B (en) | A pharmaceutical composition | |
| IL185390A0 (en) | A solid pharmaceutical dosage formulation | |
| EP1898922A4 (en) | MEDICINE OR IMPROVED PHARMACEUTICAL COMPOUNDS AND PREPARATION THEREOF | |
| IL221323A0 (en) | 1-methyl-1h- pyridin-2-one- phenanthridine derivatives and pharmaceutical compositions containing the same | |
| IL182703A0 (en) | Pharmaceutical compositions comprising a camtothecin derivative | |
| IL183986A0 (en) | Pharmaceutical compounds and compositions | |
| IL177168A0 (en) | N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same | |
| PT1701698E (pt) | Composição farmacêutica para a administração oral de cci-779 | |
| EP1757273A4 (en) | PREPARATION FOR ORAL ADMINISTRATION | |
| IL181730A0 (en) | Benzodiazinone derivatives and pharmaceutical compositions containing the same | |
| IL181938A0 (en) | Lercanidipine capsules | |
| EP1778252A4 (en) | NON-CARDIOTOXIC PHARMACEUTICAL COMPOUNDS | |
| GB0400452D0 (en) | A pharmaceutical composition | |
| IL177498A0 (en) | Difluoroethoxy -substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same | |
| IL177497A0 (en) | Isoamido-substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same | |
| GB0424742D0 (en) | Pharmaceutical compounds | |
| PL373776A1 (en) | Oral pharmaceutical compound | |
| GB0522473D0 (en) | A pharmaceutical formulation | |
| GB0613761D0 (en) | A pharmaceutical formulation and method for the preparation thereof | |
| IL178665A0 (en) | Dialkoxy-imidazopyridine derivatives and pharmaceutical compositions containing the same | |
| IL179725A0 (en) | Amino-halogen-imidazopyridine derivatives and pharmaceutical compositions containing the same | |
| GB0413138D0 (en) | Preparation for oral administration | |
| ZA200703549B (en) | Lercanidipine capsules |